Bicalutamide: A potential new oral antiandrogenic drug for female pattern hair loss

J Am Acad Dermatol. 2020 Nov;83(5):e355-e356. doi: 10.1016/j.jaad.2020.04.054. Epub 2020 Apr 19.

Authors

Diego Fernandez-Nieto¹, David Saceda-Corralo², Juan Jimenez-Cauhe³, Oscar Muñoz Moreno-Arrones², Rita Rodrigues-Barata², Angela Hermosa-Gelbard³, Sergio Vano-Galvan²

Affiliations

¹ Dermatology Department, Trichology Unit, Ramon y Cajal University Hospital, Madrid, Spain. Electronic address: fnietodiego@gmail.com.
² Dermatology Department, Trichology Unit, Ramon y Cajal University Hospital, Madrid, Spain; Trichology Unit, Grupo de Dermatología Pedro Jaen, Madrid, Spain.
³ Dermatology Department, Trichology Unit, Ramon y Cajal University Hospital, Madrid, Spain.

PMID: 32320770
DOI: 10.1016/j.jaad.2020.04.054

No abstract available

Publication types

Letter
Comment

MeSH terms

Alopecia / drug therapy
Androgen Antagonists
Anilides
Female
Humans
Nitriles
Pharmaceutical Preparations*
Retrospective Studies
Tosyl Compounds*

Substances

Androgen Antagonists
Anilides
Nitriles
Pharmaceutical Preparations
Tosyl Compounds
bicalutamide